Treatment for Croup in Children
All children presenting with croup should receive a single dose of oral dexamethasone 0.15-0.60 mg/kg (with 0.15 mg/kg likely as effective as higher doses), and those with moderate-to-severe croup should additionally receive nebulized racemic epinephrine. 1, 2
Core Treatment Algorithm
First-Line Treatment: Corticosteroids for ALL Severities
- Administer dexamethasone orally as the primary treatment regardless of croup severity 1, 2, 3
- Dosing: 0.15 mg/kg is as effective as the traditional 0.60 mg/kg dose 1, 4
- The lower dose (0.15 mg/kg) reduces medication burden while maintaining efficacy
- Maximum benefit seen at 6-12 hours post-administration 1
- Alternative: Nebulized budesonide 2 mg can be used if the child cannot tolerate oral medication 3
Evidence strength: This recommendation is supported by high-certainty evidence from a 2023 Cochrane review of 45 RCTs involving 5,888 children, showing glucocorticoids significantly reduce croup scores at 2,6, and 12 hours compared to placebo 1. Corticosteroids reduce return visits, shorten hospital stays, and decrease need for additional treatments 1, 5.
Second-Line Treatment: Nebulized Epinephrine for Moderate-to-Severe Cases
- Indications: Presence of stridor at rest with increased work of breathing (intercostal retractions, nasal flaring, tachypnea) 3
- Administration: Nebulized racemic epinephrine or L-epinephrine 4
- Observation requirement: Monitor for at least 4 hours after epinephrine administration due to potential rebound symptoms 6, 7
Hospital Admission Criteria
Consider admission only after 3 doses of racemic epinephrine have been administered 6. This approach led to a 37% reduction in hospital admissions without increasing revisits or readmissions in a 2022 quality improvement study 6.
Admit if:
- Persistent respiratory distress after 3 doses of epinephrine
- Inability to maintain adequate oxygenation
- Signs of impending respiratory failure
- Social factors preventing safe discharge
Important Clinical Pitfalls
What NOT to Do
- Do not use humidified air or cool mist therapy - no demonstrable benefit in acute settings despite historical practice 4
- Do not withhold corticosteroids in mild cases - this is the most common adherence failure, particularly in outpatient settings 7
- Do not discharge immediately after epinephrine - observe for minimum 4 hours 6
Practice Variation Issues
A 2026 study found that corticosteroid prescription showed the lowest adherence rates, particularly for mild croup cases 7. Paediatricians in outpatient settings were more likely to have incomplete guideline adherence 7. This represents a significant quality gap since corticosteroids benefit all severity levels 1, 5.
Comparison: Dexamethasone vs. Prednisolone
Dexamethasone is preferred over prednisolone because it:
- Reduces return visits/readmissions by approximately 45% (RR 0.55) 1
- Decreases need for supplemental glucocorticoids by 28% (RR 0.72) 1
- Shows equivalent symptom reduction at 2 and 6 hours 1
This is moderate-to-high certainty evidence from direct comparison trials 1.
Special Considerations
Recurrent Croup
For children with >5 episodes of croup, prophylactic inhaled corticosteroids initiated at first sign of viral prodrome showed 86.7% improvement in reducing frequency and severity 8. This is particularly effective in patients without fixed airway lesions 8.
Cost and Value
Implementation of evidence-based guidelines reduced admission rates without increasing emergency department length of stay or readmissions 6. The median reduction in charges was $150 per encounter, with potential for millions in annual healthcare savings nationally 6.